Director, Diagnostic Sciences & Partnerships
Novartis Pharmaceutical Corp.
East Hanover, New Jersey, United States
Jim Glick joined Novartis’ Global Drug Development Precision Medicine Diagnostic Sciences & Partnerships group in 2022 after 9 years in NIBR’s Translational Medicine PK Sciences group. In this role, he ensures assays used for patient inclusion/exclusion and primary and secondary clinical endpoints meet the needed technical, regulatory and compliance frameworks for diagnostic assays. In his previous 9 years at NIBR, he supported both preclinical and clinical programs as a lab head in the Bioanalytical group supporting GLP Toxicology studies, IND and BLA filings for multiple programs. Before joining Novartis, he was the Director of the Barnett Institute’s Core Mass Spectrometry facility and Lecturer in Analytical Chemistry and Instrumental Analysis at Northeastern University. Jim received his Ph.D. from Northeastern University in Boston MA in the Department of Chemistry and Chemical Biology with an emphasis in Analytical Chemistry.
Disclosure information not submitted.
Monday, April 24, 2023
2:30 PM – 2:45 PM ET